Clinical Trial Update: Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for autologous adipose tissue-derived mesenchymal progenitor cell therapy in knee osteoarthritis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Autologous adipose tissue-derived mesenchymal progenitor cells (MPCs) therapy (Mesenchymal progenitor cells)

Snippet

Sponsor: Shanghai AbelZeta Ltd. | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED